How the Covid-19 vaccine crisis is putting the EU in danger
The botched coronavirus vaccine campaign will cause long-term harm to the EU's economy, says Matthew Lynn.


Export controls may be imposed. Supplies are being held up at factories. Police in Italy are carrying out raids, looking for any evidence of stock being withheld or sent abroad. The grim farce of the European Union’s coronavirus vaccine crisis has taken twist after twist.
Supplies will soon pick up: so much has been ordered that the developed world at least will be awash with vaccines. The continent will finally be able to get on with inoculating its citizens by summer. But this will not end the long-term consequences of this crisis. They will run and run.
A catastrophe from the start
The EU’s vaccination campaign has been a catastrophe. The European Commission hijacked procurement, bought the wrong vaccines, in the wrong quantities, put itself at the back of the queue, and failed to invest in ramping up production. It dithered and delayed over the approvals process. Its leaders cast doubts on the effectiveness of the one jab that was available in large quantities. Regulators suspended it on the flimsiest of evidence, holding up the roll-out for several days for no reason.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The statistics make it clear how badly this has gone. While the UK has given over half the adult population at least one shot, with the United States not far behind, major European countries such as France, Italy, Spain and Germany are still on less than 10%. So while infections, and more importantly deaths and hospitalisations, are collapsing in the UK and the US, Europe is going back into another lockdown.
That means economies will be shut for far longer than they otherwise would have been. Israel has opened up, the US is following behind, and Britain will start getting back to normal this month. Shops, restaurants and gyms will all welcome customers again. By contrast, Germany, France and Italy are all imposing fresh restrictions, meaning the recession will drag on for at least another three months, and governments will have to run up more debt to pay for it. Lost output will eventually be recovered as the virus comes under control, but the debt will stick around.
The EU has also done huge damage to its reputation. As it panics over the supply of vaccines, the Commission has trashed property rights and suspended the rule of law. It has seized supplies and blocked companies from exporting with, so far as anyone can tell, no right of appeal, or any form of due process. There is simply bureaucratic fiat deciding who you can sell to and who you can’t.
Vaccine manufacturing, a major industry for the EU, is going to suffer. Every sensible government is going to make sure it has its own plants, given that it now knows in a pandemic the EU will seize factories. But the effects will go further than that. Every manufacturer will be wondering what might happen to their production lines in an emergency and may conclude the EU is not a safe place to invest anymore.
Expect political chaos
Finally, it will unleash political chaos. Ursula von der Leyen, the president of the European Commission, is now surely a lame duck. There is no mechanism for getting rid of her, but she won’t be able to drive through any new programmes. That matters. The EU still needs to get its vaccination programme back on track. It needs to implement that Coronavirus Rescue Fund to stimulate devastated economies in southern Europe. Beyond that, there is still the task of restoring the zone’s competitiveness. But it is unlikely anyone will be listening to her now.
Meanwhile German elections in the autumn may sweep the Greens to power at the head of a ramshackle coalition. In France, it is hard to see Emmanuel Macron winning reelection next spring if he can’t get the virus under control. In Italy, Mario Draghi may not survive long if he can’t get jabs into people’s arms. Europe is about to go through a year of intense political uncertainty. It was already the least-attractive region in the world for investors. The vaccine crisis has made perceptions far worse. Recovery could take years.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew Lynn is a columnist for Bloomberg, and writes weekly commentary syndicated in papers such as the Daily Telegraph, Die Welt, the Sydney Morning Herald, the South China Morning Post and the Miami Herald. He is also an associate editor of Spectator Business, and a regular contributor to The Spectator. Before that, he worked for the business section of the Sunday Times for ten years.
He has written books on finance and financial topics, including Bust: Greece, The Euro and The Sovereign Debt Crisis and The Long Depression: The Slump of 2008 to 2031. Matthew is also the author of the Death Force series of military thrillers and the founder of Lume Books, an independent publisher.
-
What makes you wealthy in the UK? Could it make you a target in Rachel Reeves’ Budget?
Wealthy Brits could be at risk from a Budget tax raid – but how much money do you need to be considered wealthy in the UK?
-
More retirees are buying inflation-protected annuities. What are they and how do they work?
Sales of annuities where the income on offer increases every year have surged – and more people are also taking up enhanced rates that are higher due to illness
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?
-
The Palace of Westminster is falling down
The Palace of Westminster is in need of repair, but the bill is prohibitive, says Simon Wilson
-
'Gen Z is facing an AI jobs bloodbath'
Opinion It has always been tough to get your first job, but this year, it's proving tougher than ever. AI is to blame, says Matthew Lynn
-
Should the Online Safety Act survive?
The Online Safety Act, a measure to safeguard children, is having unintended consequences
-
The secret behind Sweden’s success
Opinion Sweden's stock market is in rude health, says Max King. Why can't Britain follow suit?
-
Prabowo Subianto: Indonesia’s Deng Xiaoping
Prabowo Subianto, like his Chinese hero, is taking power in his 70s with big ambitions for his country. Yet many view his return to politics with dread